Ofosu FA - Search Results

1

Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.

Okwusidi JI, Anvari N, Kulczycky M, Blajchman MA, Buchanan MR, Ofosu FA. Okwusidi JI, et al. Among authors: ofosu fa. J Lab Clin Med. 1991 May;117(5):359-64. J Lab Clin Med. 1991. PMID: 2019790

2

Antithrombotic properties of heparin in a neonatal piglet model of thrombin-induced thrombosis.

Schmidt B, Buchanan MR, Ofosu F, Brooker L, Hirsh J, Andrew M. Schmidt B, et al. Thromb Haemost. 1988 Oct 31;60(2):289-92. Thromb Haemost. 1988. PMID: 3217922

3

Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.

Ofosu FA, Fareed J, Smith LM, Anvari N, Hoppensteadt D, Blajchman MA. Ofosu FA, et al. Eur J Biochem. 1992 Jan 15;203(1-2):121-5. doi: 10.1111/j.1432-1033.1992.tb19836.x. Eur J Biochem. 1992. PMID: 1730217 Free article.

4

Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.

Ofosu FA, Choay J, Anvari N, Smith LM, Blajchman MA. Ofosu FA, et al. Eur J Biochem. 1990 Oct 24;193(2):485-93. doi: 10.1111/j.1432-1033.1990.tb19363.x. Eur J Biochem. 1990. PMID: 2226466 Free article.

5

Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.

Ofosu FA, Buchanan MR, Anvari N, Smith LM, Blajchman MA. Ofosu FA, et al. Ann N Y Acad Sci. 1989;556:123-31. doi: 10.1111/j.1749-6632.1989.tb22496.x. Ann N Y Acad Sci. 1989. PMID: 2525356

6

Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits.

Blajchman MA, Young E, Ofosu FA. Blajchman MA, et al. Among authors: ofosu fa. Ann N Y Acad Sci. 1989;556:245-54. doi: 10.1111/j.1749-6632.1989.tb22507.x. Ann N Y Acad Sci. 1989. PMID: 2544126 No abstract available.

7

Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.

Van Ryn-McKenna J, Ofosu FA, Gray E, Hirsh J, Buchanan MR. Van Ryn-McKenna J, et al. Among authors: ofosu fa. Ann N Y Acad Sci. 1989;556:304-12. doi: 10.1111/j.1749-6632.1989.tb22512.x. Ann N Y Acad Sci. 1989. PMID: 2735661

8

Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.

Ofosu FA, Hirsh J, Esmon CT, Modi GJ, Smith LM, Anvari N, Buchanan MR, Fenton JW 2nd, Blajchman MA. Ofosu FA, et al. Biochem J. 1989 Jan 1;257(1):143-50. doi: 10.1042/bj2570143. Biochem J. 1989. PMID: 2920007 Free PMC article.

9

Is heparin the ideal anticoagulant for cardiopulmonary bypass? Dermatan sulphate may be an alternate choice.

Brister SJ, Ofosu FA, Heigenhauser GJ, Gianese F, Buchanan MR. Brister SJ, et al. Among authors: ofosu fa. Thromb Haemost. 1994 Apr;71(4):468-73. Thromb Haemost. 1994. PMID: 8052965

10

Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: importance of heparin cofactor II.

Buchanan MR, Liao P, Smith LJ, Ofosu FA. Buchanan MR, et al. Among authors: ofosu fa. Thromb Res. 1994 Jun 1;74(5):463-75. doi: 10.1016/0049-3848(94)90267-4. Thromb Res. 1994. PMID: 8085247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters